Jordan Summerside is a GentiBio Board Observer and is the Associate Vice President, Innovation & New Ventures at Seattle Children’s, leading the expansion of the research division’s innovation ecosystem and commercialization strategy. As the AVP, Jordan engages in leadership and oversight for industry partnerships and other Seattle Children’s spinouts promoting translation of novel technologies and scientific discoveries into opportunities that benefit patients. Prior to his role, he led business transactions and system partnerships, notably the restructuring of the Seattle Cancer Care Alliance into the Fred Hutch Cancer Center, and the creation of BrainChild Bio, a clinical-stage biotech company spinout of Seattle Children’s.
Jordan Summerside
Associate Vice President, Innovation & New Ventures, Seattle Children’s, Board Observer
